Access cutting-edge colon cancer treatment through this clinical trial at a research site in New York. Study-provided care at no cost to qualified participants.
Access colon cancer specialists in New York at no cost
This study follows strict safety protocols and ethical guidelines
All study-related colon cancer treatment provided free
This research study is comparing two standard of care treatment options based on blood test results for participants who have metastatic colon cancer. The names of the potential treatments involved in this study are: * Active surveillance * FOLFIRI treatment * Nivolumab treatment * Encorafenib/Binimetinib/Cetuximab treatment * Trastuzumab + Pertuzumab
Sponsor: Massachusetts General Hospital
Check if you qualify for this colon cancer clinical trial in New York, NY
If you're searching for colon cancer treatment options in New York, NY, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our New York research site is actively enrolling participants for this clinical trial. You'll receive care from experienced colon cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.